Meet AVEVA at CPhI 2007
05 September 2007
Leading developer of transdermal drug delivery solutions Aveva exhibited at CPhl 2007 in Italy earlier this autumn.
During the exhibition Aveva showcased some of the very latest technology on offer to the medical device and drug delivery market, as well as the latest research and licensing projects regarding subjects including:
- Sufentl
- Fentanyl
- Nicotine
- Clonidine
- Co-development projects
- Compound patch feasibility
- Contract manufacturing
For further information regarding Aveva and its products, please select the link below.
